Abstract

7-11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

Details

Title
Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients
Author
Jansen, K 1 ; Sönnerborg, A 2 ; Pugliese, P 3 ; Biguenet, S 4 ; Eychenne, J L 5 ; Brockmeyer, N H 6 ; Michalik, C 7 ; Dupke, S 8 ; Jaeger, H 9 ; Plettenberg, A 10 ; Butcher, D 11 ; Jiménez-Expósito, MJ 11 ; KompNet, HIV 1 

 Competence Network for HIV/AIDS, Bochum, Germany 
 Karolinska Institutet, Karolinska University Hospital, Department of Infectious Diseases, Stockholm, Sweden 
 Nice University Hospital, Infectious Diseases Department, Nice, France 
 Bristol-Myers Squibb Company, Wallingford, CT, USA 
 Hays Pharma, Paris, France 
 Clinic for Dermatology, Venerology, and Allergolog, Competence Network for HIV/AIDS, Bochum, Germany 
 Clinical Trial Centre, Cologne, Germany 
 Clinical Centre Driesener Straße, Berlin, Germany 
 MVZ Karlsplatz, Munich, Germany 
10  Ifi-Institut, Hamburg, Germany; 
11  Bristol-Myers Squibb Company, Paris, France 
Pages
P31-P31
Section
Poster Presentation
Publication year
2010
Publication date
Nov 2010
Publisher
John Wiley & Sons, Inc.
e-ISSN
1758-2652
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3067616271
Copyright
© 2010. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.